Skip to main content

Rhenman & Partners Asset Management AB

Position in KRYS — Krystal Biotech, Inc.

CIK 1599882 Stockholm, V7

Position in KRYS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$6,067,512
+$1,760,026 QoQ
Shares Held
16,325
-2.1% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#98
of 419 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KRYS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rhenman & Partners Asset Management AB holds $335,352,902 across 39 Biotechnology names. KRYS ranks #25 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KRYS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,067,512 16,325
2026-03-31 $4,307,486 16,675
2025-12-31 $6,163,500 25,000
2025-09-30 $2,074,227 11,750
2025-06-30 $1,752,615 12,750
2025-03-31 $3,200,325 17,750
2024-12-31 $3,720,675 23,750
2024-09-30 $3,094,510 17,000
2024-06-30 $3,489,160 19,000
2024-03-31 $3,380,670 19,000